http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011032187-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b43aead5e8105aca09598689ed2a2737
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64
filingDate 2009-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70519fe73f9df3430456d5055689db2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e5bc6b5d55fe94096708462c49b385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35b0b06e3d821e57e1b490d51e808f7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89ec20471f78650bd5ab00ea761cf0b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cad6648dc863a2bac4ab7e7962c9b10f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91c60b50fad0f77ffa72ecc56e20a0a0
publicationDate 2011-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2011032187-A
titleOfInvention Royal jelly extract and human osteoblast growth inhibitor
abstract PROBLEM TO BE SOLVED: To find a new pharmacologically active ingredient contained in royal jelly. SOLUTION: Adenosine, adenosine N1-oxide, adenosine-5′-monophosphate (5 ′) contained in an aqueous extract of royal jelly fractionated to a molecular weight of 2000 or less. AMP), adenosine-5'-monophosphate-N1-oxide (AMP N1-oxide), nicotinamide adenine dinucleotide (NAD + ), nicotinamide adenine dinucleotide-N1-oxide (NAD + N1-oxide) At least one of these is used as an active ingredient of a human osteoblast growth inhibitor. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295627-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013089131-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3130332-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10071042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012056891-A
priorityDate 2009-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005287411-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006290813-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004075543-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001029039-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005179235-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010111646-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04311357-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID459896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226913559

Total number of triples: 43.